Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
US-2018244611-A1 · Aug 30, 2018 · US
US10428273B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10428273-B2 |
| Application number | US-201715655918-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 21, 2017 |
| Priority date | Jul 22, 2016 |
| Publication date | Oct 1, 2019 |
| Grant date | Oct 1, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Shown are a liquid crystal compound satisfying at least one of physical properties such as high stability to heat and light, a high clearing point (or high maximum temperature), low minimum temperature of a liquid crystal phase, small viscosity, suitable optical anisotropy, large negative dielectric anisotropy, a suitable elastic constant and satisfactory compatibility with other liquid crystal compounds, a liquid crystal composition containing the compound and a liquid crystal display device including the composition. A compound is represented by formula (1), a liquid crystal composition contains the compound, or the like
Opening claim text (preview).
What is claimed is: 1. A liquid crystal composition, containing at least one compound represented by formula (1) as component (a): wherein, in formula (1), R 1 and R 2 are independently hydrogen, alkyl having 1 to 16 carbons, alkenyl having 2 to 16 carbons, cyclopropyl, cyclobutyl or cyclopentyl, and in the alkyl and the alkenyl, at least one —CH 2 —is optionally replaced by —O—, —S—, —CO—, —COO—, —OCO—, —OCOO—, —C≡C—, cyclopropane-1,2-diyl or —Si(CH 3 ) 2 —, and in the groups, at least one hydrogen is optionally replaced by fluorine or chlorine, and in the groups, at least one —CH 3 is optionally replaced by any one of monovalent groups (G1) to (G4) below; wherein, in groups (G1) to (G4), R 3 is alkyl having 1 to 12 carbons or alkenyl having 2 to 12 carbons, and in the alkyl and the alkenyl, at least one —CH 2 — is optionally replaced by —O—, and in the groups, at least one hydrogen is optionally replaced by fluorine or chlorine; and in formula (1), ring A 1 and ring A 2 are independently 1 ,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, decahydronaphthalene-2,6-diyl, tetrahydronaphthalene-2,6-diyl or naphthalene-2,6-diyl, and in the groups, one or two pieces of —CH 2 — is optionally replaced by —O—, —S—, —CO—, —CF 2 —, —SiH 2 — or —Si(CH 3 ) 2 —, and one or two pieces of —CH 2 CH 2 — is optionally replaced by —CH═CH— or —CH═N—, and in the groups, at least one hydrogen on an aromatic ring is optionally replaced by halogen, —CF 3 , —CHF 2 , —CH 2 F, —OCF 3 , —OCHF 2 , —OCH 2 F, or —C≡N; Z 1 and Z 2 are independently a single bond or alkylene having 1 to 4 carbons, and one —CH 2 — is optionally replaced by —O— or —CO—, and at least one —CH 2 CH 2 — is optionally replaced by —CH═CH— or —C≡C—, and in the groups, at least one hydrogen is optionally replaced by fluorine or chlorine; X, L 1 and L 2 are independently hydrogen or halogen; Y is —CO— or —CF 2 —; and a and b are independently 0, 1 or 2. 2. The liquid crystal composition according to claim 1 , further containing at least one compound selected from the group of compounds represented by formulas (2) to (4) as component (b): wherein, in formulas (2) to (4), R 11 and R 12 are independently alkyl having 1 to 10 carbons or alkenyl having 2 to 10 carbons, and in the alkyl and the alkenyl, at least one —CH 2 —is optionally replaced by —O—, and in the groups, at least one hydrogen is optionally replaced by fluorine; ring B 1 , ring B 2 , ring B 3 and ring B 4 are independently 1,4-cyclohexylene, 1,4-phenylene, 2-fluoro-1,4-phenylene, 2,5-difluoro-1,4-phenylene or pyrimidine-2,5-diyl; and Z 11 , Z 12 and Z 13 are independently a single bond, —COO—, —CH 2 CH 2 —, —CH═CH— or C≡C—. 3. The liquid crystal composition according to claim 1 , wherein component (a) is at least one compound represented by formula (1-1): wherein, in formula (1-1), R 1 and R 2 are independently hydrogen, alkyl having 1 to 14 carbons or alkenyl having 2 to 14 carbons, and in the alkyl and the alkenyl, one or two pieces of —CH 2 — is optionally replaced by —O—, and in the groups, at least one hydrogen is optionally replaced by fluorine, and in the groups, at least one —CH 3 is optionally replaced by any one of monovalent groups (G1) to (G4) below; wherein, in groups (G1) to (G4), R 3 is alkyl having 1 to 10 carbons, and in the alkyl, at least one —CH 2 — is optionally replaced by —O—; and in formula (1-1), ring A 1 and ring A 2 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, decahydronaphthalene-2,6-diyl, tetrahydronaphthalene-2,6-diyl or naphthalene-2,6-diyl, and in the groups, one or two pieces of —CH 2 — is optionally replaced by —O—, and one or two pieces of —CH 2 CH 2 — is optionally replaced by —CH═CH—, and in the groups, at least one hydrogen on an aromatic ring is optionally replaced by fluorine; Z 1 and Z 2 are independently a single bond, —O—, —COO—, —OCO—, —CH 2 O—, —OCH 2 —, —CF 2 O—, —OCF 2 —, —CH 2 CH 2 —, —CF 2 CF 2 —, —CH═CH—, —CF═CF—, —C≡C—, —(CH 2 ) 4 — or —CH 2 CH═CHCH 2 —; X is hydrogen, fluorine or chlorine; Y is —CO— or —CF 2 —; and a and b are independently 0, 1 or 2. 4. The liquid crystal composition according to claim 3 , wherein, in formula (1-1), R 1 and R 2 are independently hydrogen, alkyl having 1 to 14 carbons or alkenyl having 2 to 14 carbons, and in the alkyl and the alkenyl, one or two pieces of —CH 2 — is optionally replaced by —O—, and in the groups, at least one hydrogen is optionally replaced by fluorine; ring A 1 and ring A 2 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,3-dioxane-2,5-diyl, tetrahydropyran-2,5-diyl, 1,4-phenylene, 3 -fluoro-1,4-phenylene, 3,5-difluoro-1,4-phenylene, pyridine-2,5-diyl or pyrimidine-2,5-diyl; Z 1 and Z 2 are independently a single bond, —O—, —COO—, —OCO—, —CH 2 O—, —OCH 2 —, —CF 2 O—, —OCF 2 —, —CH 2 CH 2 — or —CH═CH—; X is hydrogen or fluorine; Y is —CO— or —CF 2 —; and a and b are independently 0, 1 or 2, and a sum of a and b is 0, 1 or 2. 5. The liquid crystal composition according to claim 3 , wherein, in formula (1-1), R 1 and R 2 are independently alkyl having 1 to 8 carbons, alkoxy having 1 to 8 carbons or alkenyl having 2 to 8 carbons; ring A 1 and ring A 2 are independently 1,4-cyclohexylene, 1,4-phenylene or 1,4-phenylene in which at least one hydrogen is replaced by fluorine; Z 1 and Z 2 are independently a single bond, —O—, —COO—, —OCO—, —CH 2 O—, —OCH 2 — or —CH 2 CH 2—; X is hydrogen or fluorine; Y is —CO— or —CF 2 —; and a and b are independently 0, 1 or 2, and a sum of a and b is 0, 1 or 2. 6. The liquid crystal composition according to claim 1 , wherein component (a) is at least one compound selected from the group of compounds represented by formulas (1a) to (1t): wherein, in formulas (1a) to (1), R 1 and R 2 are independently alkyl having 1 to 12 carbons, alkoxy having 1 to 12 carbons or alkenyl having 2 to 12 carbons; X is hydrogen, fluorine or chlorine; and Y is —CO— or —CF 2 —. 7. The liquid crystal composition according to claim 1 , wherein component (a) is at least one compound selected from the group of compounds represented by formulas (1 a-1) to (1 t-1): wherein, in formulas (1a-1) to (1t-1), R 1 and R 2 are independently alkyl having 1 to 12 carbons, alkoxy having 1 to 12 carbons or alkenyl having 2 to 12 carbons; and X is hydrogen or fluorine. 8. The liquid crystal composition according to claim 1 , wherein component (a) is at least one compound selected from the group of compounds represented by formulas (1 a-11) and (1a-12):
linked by a carbon chain containing alicyclic rings · CPC title
Cy-C2H4-Ph-Ph · CPC title
Ph-C≡C-Ph · CPC title
Six-membered ring with oxygen(s) in fused, bridged or spiro ring systems · CPC title
Cy-Ph-Ph-Cy · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.